Kiffik Biomedical, a leader in interstitial fluid (ISF)-based diagnostics, has announced a strategic partnership with Rubix ...

UK£1.11m (loss narrowed by 39% from 1H 2024). UK£0.001 loss per share (improved from UK£0.005 loss in 1H 2024). Don't forget ...

NEVADA CITY, CA / / March 20, 2025 / Telestream, a global leader in media workflow technologies, is extending its leadership ...

The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” in its ...

UP Diliman biologists create an aptamer-based test for trichomoniasis detection, offering a potentially faster and more ...

Schematic representation of the assay. (Photo credit: Justo et al., 2024) Using the knowledge gained in the sandwich ELAA ...

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” in its interim results for the six months ending December 31.

York-based biotech firm, the Aptamer Group, has reported “revenue growth, solid cash position and strong technical progress” ...